182 related articles for article (PubMed ID: 8554733)
1. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
Chan P; Lee CB; Lin TS; Ko JT; Pan WH; Lee YS
Am J Hypertens; 1995 Nov; 8(11):1099-104. PubMed ID: 8554733
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of pravastatin in hypertensive hypercholesterolaemic patients on antihypertensive drug therapy.
Celis H; Lijnen P; Fagard R; Staessen J; Thijs L; Amery A
J Hum Hypertens; 1994 Jul; 8(7):525-30. PubMed ID: 7932517
[TBL] [Abstract][Full Text] [Related]
3. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
7. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
8. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects.
Chan P; Tomlinson B; Lee CB; Pan WH; Lee YS
Hypertension; 1996 Oct; 28(4):647-51. PubMed ID: 8843892
[TBL] [Abstract][Full Text] [Related]
10. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
Beigel Y; Brook G; Eisenberg S; Fainaru M; Harats D; Levy Y; Rubinstein A; Skurnik Y
Isr J Med Sci; 1993 May; 29(5):272-7. PubMed ID: 8314685
[TBL] [Abstract][Full Text] [Related]
13. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.
Pan HY; DeVault AR; Brescia D; Willard DA
Clin Ther; 1991; 13(3):368-72. PubMed ID: 1954638
[TBL] [Abstract][Full Text] [Related]
15. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
Brown WV; Bays HE; Hassman DR; McKenney J; Chitra R; Hutchinson H; Miller E;
Am Heart J; 2002 Dec; 144(6):1036-43. PubMed ID: 12486428
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
[TBL] [Abstract][Full Text] [Related]
18. [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study].
Ferrari P; Weidmann P; Riesen WF; Martius F; Luban S; Pasotti E; Erne P; Fragiacomo C; Noseda G; Reutter F
Schweiz Med Wochenschr; 1993 Sep; 123(37):1736-41. PubMed ID: 8211024
[TBL] [Abstract][Full Text] [Related]
19. Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment.
Takeshita M; Katsuragi Y; Kusuhara M; Higashi K; Miyajima E; Mizuno K; Mori K; Obata T; Ohmori R; Ohsuzu F; Onodera Y; Sano J; Sawada S; Tabata S; Tokimitsu I; Tomonobu K; Yamashita T; Yasukawa T; Yonemura A; Nakamura H
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):483-91. PubMed ID: 17964767
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]